Latest updates for Ai Drug Discovery

Fresh curated links around AI drug discovery are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Why AI Alone Isn’t Enough for Oligonucleotide Discovery
  • AI Lab Partners Are Rewiring the Hunt for New Drugs
  • Patent Analysis is Increasingly Shaping AI-Driven Target and Drug Candidate Selection

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

genengnews.com /2 weeks ago

Why AI Alone Isn’t Enough for Oligonucleotide Discovery

Large-scale screening campaigns are essential as they provide the dense, reliable, datasets required to train AI models and extract meaningful insights for sequence and chemistry p...

Read source
singularityhub.com /1 week ago

AI Lab Partners Are Rewiring the Hunt for New Drugs

Researchers used two AI systems, Robin and Co-Scientist, to collapse the timeline from idea to drug candidate. The post AI Lab Partners Are Rewiring the Hunt for New Drugs appeared...

Read source
natlawreview.com /1 month ago

Patent Analysis is Increasingly Shaping AI-Driven Target and Drug Candidate Selection

Pun et al.’s recent review entitled “Target identification and assessment in the era of AI” in Nature Reviews Drug Discovery maps how artificial intelligence (AI) is widening targe...

Read source
fiercebiotech.com /2 weeks ago

Utilizing AI to Facilitate Combination Product Development

Specific examples of AI/ML usage by pharma companies through the combination product development process

Read source
genengnews.com /1 week ago

AI Designs Miniprotein Switches for GPCR Targeting

New AI‑designed miniproteins precisely modulate GPCR signaling and reveal a new "receptor diversion" microscopy-based screening system for targeting receptors long considered diffi...

Read source
nanowerk.com /1 month ago

AI helps chemists design molecules step by step

AI guides molecular design by combining language models with traditional chemistry tools, helping plan reaction steps and decode mechanisms with expert-level strategic reasoning.

Read source
fiercebiotech.com /2 weeks ago

Why Model Medicines needs to ‘discover new colors’ in its AI drug discovery quest

“Outliers are what you're going for,” Model Medicines CEO Daniel Haders, Ph.D., told Fierce to explain the company's AI-driven drug development strategy.

Read source
genengnews.com /1 month ago

Can AI Agents Automate Scientific Discovery?

From designing drugs with a text prompt to XR-guided experiments, agentic AI is transforming the modern lab. NVIDIA GTC brought together life science leaders to discuss how these a...

Read source
biopharmadive.com /1 month ago

An ‘AI scientist’ can tackle drug R&D. What does that mean for pharma?

A new tool is giving researchers a “data center full of genius Ph.D. students in their pocket.”

Read source
thenextweb.com /1 month ago

AI can screen 15 million molecules in a day. It still can’t cure Alzheimer’s.

The drug discovery revolution is real but radically overstated, the health chatbots are a documented hazard, and the diseases that matter most remain stubbornly unsolved. At Novart...

Read source
wired.com /1 month ago

AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials

Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”

Read source
inc.com /1 month ago

The Drug Discovery Process Is Cumbersome. Amazon Wants to Fix It With AI

The tech giant’s new AI platform aims to make drug discovery faster and cleaner.

Read source
genengnews.com /3 weeks ago

CoCoGraph AI Model Generates Molecules that Comply with Rules of Chemistry

Discovering viable new molecules is challenging due to the vastness of the search space. CoCoGraph uses a diffusion model, a technique common in image generation, to generate reali...

Read source
genengnews.com /1 week ago

Skape Bio Unlocks Generalizable GPCR Drugs Using AI Protein Design

David Baker’s latest company is making medicines for a huge protein family once deemed undruggable. A new study generated miniproteins that target GPCRs across a diversity of recep...

Read source
biopharmadive.com /3 weeks ago

What is your AI drug repurposing strategy missing?

Fragmented data limits even the most advanced oncology AI. Curated knowledge changes that.

Read source
techcrunch.com /1 month ago

AI is spitting out more potential drugs than ever. This startup wants to figure out which ones matter.

10x Science has raised a $4.8 million seed round to help pharmaceutical researchers understand complex molecules.

Read source
fiercebiotech.com /1 week ago

Incyte inks deal with Edison Scientific to train AI through drug discovery

Incyte and Edison Scientific have signed a collaboration to employ Edison’s AI scientist Kosmos in Incyte’s drug discovery and development work.

Read source
genengnews.com /1 month ago

AWS Launches Amazon Bio Discovery Agentic AI to Accelerate Drug Development

AWS's new AI platform grants researchers direct access to a broad library of biological foundation models for lab-in-the-loop drug discovery and brings enterprise-grade scale, priv...

Read source
labiotech.eu /1 month ago

AI in single-cell analysis: solving the interpretation gap

Single-cell omics is reshaping drug discovery, but turning complex data into biological insight remains slow. AI may help close the annotation gap. The post AI in single-cell analy...

Read source
genengnews.com /3 weeks ago

Big Tech Targets Drug Discovery with Wave of Life Science Platforms

AWS, OpenAI, and Anthropic have customized general-purpose assistants into AI-powered workflows for science research, pointing to the growing role of cloud infrastructure and agent...

Read source
nanowerk.com /1 week ago

Accelerating discovery with AI

Automating electron microscopy experimental design with agentic AI

Read source
arstechnica.com /1 week ago

Two AI-based science assistants succeed with drug-retargeting tasks

Both tools generate hypotheses; one goes on to analyze some of the data.

Read source
bioengineer.org /1 month ago

DeepDrugDiscovery Finds BBB-Permeable Autophagy Enhancers

In a groundbreaking leap for neurodegenerative disease therapeutics, researchers have unveiled DeepDrugDiscovery, an innovative AI-driven screening platform designed to identify no...

Read source
biopharmadive.com /1 month ago

Novo teams with OpenAI; Ideaya gets muted response to eye drug data

Novo intends to “fully integrate” AI capabilities across its operations. Elsewhere, Regeneron made its first foray into radiopharmaceuticals and a GSK cancer drug showed early prom...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Ai Drug Discovery

feeds.arstechnica.com

Recent coverage from public sources
Public source

bioengineer.org

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

singularityhub.com

Recent coverage from public sources
Public source

techcrunch.com

Recent coverage from public sources
Public source